CSIRTS // UNIFIED SECURITY ADVISORY FEEDSYS ● ONLINE · POWERED BY INTELFUSIONS.COM

CVE-2026-60597: Vulnerability in the PeopleSoft Enterprise FIN Cash Management product of Oracle PeopleSoft (component: Cash Management). The supported version that is affected is 9.2. Difficult

highCVSS 8.7CVE-2026-60597
Vulnerability in the PeopleSoft Enterprise FIN Cash Management product of Oracle PeopleSoft (component: Cash Management). The supported version that is affected is 9.2. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise PeopleSoft Enterprise FIN Cash Management. While the vulnerability is in PeopleSoft Enterprise FIN Cash Management, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all PeopleSoft Enterprise FIN Cash Management accessible data as well as unauthorized access to critical data or complete access to all PeopleSoft Enterprise FIN Cash Management accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:N).

Details

Source
NVD Recent CVEs (US · database · site)
Severity
high — CVSS 8.7
Published
2026-07-21
Last updated
2026-07-27
Exploitation
Not in CISA KEV at last sync

Original advisory: https://nvd.nist.gov/vuln/detail/CVE-2026-60597

Exploitation outlook

EPSS (FIRST.org) estimates each CVE’s probability of exploitation in the next 30 days — here is the CSIRTS.com read on those numbers.

Referenced CVEs

CVECSIRTS overviewExternal
CVE-2026-60597coverage & exploitation statusNVD · CVE.org

Same CVEs, other sources

How other CERTs, PSIRTs and databases cover the vulnerabilities in this advisory.

Recent advisories for PeopleSoft Enterprise FIN

A cluster of recent advisories against the same product widens the attack surface — attackers routinely chain freshly published CVEs on one product, so review these together.

More from NVD Recent CVEs